US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

10.94

-0.1788-1.61%

Volume:108.46K

Turnover:1.20M

Market Cap:3.71B

PE:114.70

High:11.10

Open:11.08

Low:10.94

Close:11.12

52wk High:13.11

52wk Low:6.28

Shares:339.00M

Float Shares:272.00M

Volume Ratio:1.03

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0954

EPS(LYR):-0.0211

ROE:7.36%

ROA:2.71%

PB:7.61

PE(LYR):-518.54

Loading ...

Overview Company News Filings

Telix Pharmaceuticals Price Target Maintained with a $20.00/Share by HC Wainwright & Co.

Telix Pharmaceuticals Completes Patient Enrollment in Phase Three Study of PSMA-PET Imaging Agents for Prostate Cancer Imaging

MT Newswires Live

Telix Wraps Phase 3 BiPASS Enrollment, Secures FDA NDA Pathway for Expanded PSMA-PET Use

ASX Growth Companies With High Insider Ownership You Should Know

Simply Wall St.

Press Release: Telix Appoints David Gill as Chair

Cochlear Stock And Two ASX Cash Flow Picks Trading Below Fair Value

Simply Wall St.

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.

Cash Flow Stocks Retail Investors May Be Missing In Australia

Simply Wall St.

Telix Pharmaceuticals Stock Leads 3 ASX Picks Trading Below Cash Flow Value

Simply Wall St.

3 Fast Growing Australian Stocks With High Insider Ownership Worth Watching

Simply Wall St.

ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value

Simply Wall St.

Ord Minnett Reaffirms Their Buy Rating on Telix Pharmaceuticals (TLPPF)

WiseTech Global Stock And 2 Australian Shares Trading Below Cash Flow Value

Simply Wall St.

Mesoblast Stock Leads 3 Fast Growing ASX Picks With Strong Insider Ownership

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Takeda Pharmaceutical Co (OtherTKPHF)

Cash Flow Stocks Worth A Closer Look As Bond Yields Stay High

Simply Wall St.

Jarden Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)

Mesoblast Stock Leads 3 High Growth Insider Owned ASX Shares To Watch

Simply Wall St.

Telix Pharmaceuticals Price Target Maintained with a $22.00/Share by Wedbush

Telix Pharmaceuticals: Buy Rating Reiterated with Unchanged $31 Target Ahead of Key Pixclara Regulatory Catalyst

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TLX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","market":"US","secType":"STK","nameCN":"Telix Pharmaceuticals Ltd. (Uplisting)","latestPrice":10.9412,"timestamp":1791473035993,"preClose":11.12,"halted":0,"volume":108456,"delay":0,"changeRate":-0.01607913669064739,"floatShares":272000000,"shares":339000000,"eps":0.095386,"marketStatus":"Trading","change":-0.1788,"latestTime":"10-08 11:24:14 EDT","open":11.08,"high":11.1,"low":10.935,"amount":1195473.938328,"amplitude":0.014838,"askPrice":10.95,"askSize":340,"bidPrice":10.94,"bidSize":356,"shortable":3,"etf":0,"ttmEps":0.095386,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":11.12,"preHourTrading":{"tag":"盘前","latestPrice":11,"preClose":11.12,"latestTime":"07:11 EDT","volume":174,"amount":1888.419912,"timestamp":1791457917068,"change":-0.12,"changeRate":-0.010791,"amplitude":0.036871},"postHourTrading":{"tag":"盘后","latestPrice":11.12,"preClose":11.12,"latestTime":"19:30 EDT","volume":2122,"amount":23595.9975,"timestamp":1791415802396,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.027829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","floatShares":272000000,"roa":"2.71%","roe":"7.36%","lyrEps":-0.0211,"volumeRatio":1.027829,"shares":339000000,"dividePrice":0,"high":11.1,"amplitude":0.014838,"preClose":11.12,"low":10.935,"week52Low":6.28,"pbRate":"7.61","psRate":"4.16","week52High":13.1098,"institutionHeld":0,"latestPrice":10.9412,"committee":0.022989,"eps":0.095386,"divideRate":0,"volume":108456,"delay":0,"ttmEps":0.095386,"open":11.08,"prevYearClose":7.49,"prevWeekClose":10.55,"prevMonthClose":10.97,"prevQuarterClose":10.97,"fiveDayClose":10.72,"twentyDayClose":11.9,"sixtyDayClose":11.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-19","symbol":"TLX","fiscalQuarterEnding":"2025/12","expectedEps":0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-02-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1758254400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLX","date":"2026-10-07","current":114.744302,"percent":0.27907,"low":-584.49693,"twenty":-429.411057,"median":169.604202,"eighty":241.190668,"high":383.853933,"avg":28.330875,"sd":304.807262,"marketCap":3753307402.38},"quantilePoints":[{"date":"2024-11-15","current":155.824924,"twenty":155.852142,"median":155.89297,"eighty":156.178762,"marketCap":4970652360.72},{"date":"2024-11-22","current":153.647458,"twenty":154.191824,"median":155.858947,"eighty":156.314854,"marketCap":4920980791.17},{"date":"2024-11-29","current":168.345354,"twenty":154.8995,"median":156.063085,"eighty":158.49232,"marketCap":5381208976.41},{"date":"2024-12-06","current":169.502133,"twenty":155.171684,"median":156.641474,"eighty":168.045953,"marketCap":5368295184.8},{"date":"2024-12-13","current":166.916392,"twenty":155.838533,"median":162.3233,"eighty":168.045953,"marketCap":5240175366.69},{"date":"2024-12-20","current":168.345354,"twenty":155.961016,"median":166.508117,"eighty":168.916939,"marketCap":5183140063.85},{"date":"2024-12-27","current":169.774316,"twenty":156.233199,"median":167.052484,"eighty":169.706271,"marketCap":5196235069.7},{"date":"2025-01-03","current":162.241165,"twenty":156.342072,"median":167.052484,"eighty":169.542961,"marketCap":4949346723.31},{"date":"2025-01-10","current":163.261978,"twenty":156.5326,"median":167.392713,"eighty":169.228803,"marketCap":4970930045.19},{"date":"2025-01-17","current":180.956065,"twenty":158.029608,"median":167.50507,"eighty":169.864326,"marketCap":5535715919.89},{"date":"2025-01-24","current":187.353158,"twenty":159.608271,"median":167.889662,"eighty":170.577257,"marketCap":5785750657.37},{"date":"2025-01-31","current":199.670965,"twenty":161.249345,"median":168.229933,"eighty":175.407845,"marketCap":6122321793.53},{"date":"2025-02-07","current":198.349538,"twenty":162.241165,"median":168.549491,"eighty":182.861582,"marketCap":6131109878.71},{"date":"2025-02-14","current":185.473256,"twenty":162.64949,"median":169.046583,"eighty":187.353158,"marketCap":5747906307.1},{"date":"2025-02-21","current":203.261161,"twenty":163.302811,"median":169.706271,"eighty":187.353158,"marketCap":6486347833.54},{"date":"2025-02-28","current":187.883767,"twenty":163.584606,"median":170.12499,"eighty":192.087093,"marketCap":5864055113.17},{"date":"2025-03-07","current":182.602424,"twenty":164.112905,"median":170.795004,"eighty":190.960114,"marketCap":5800401146.04},{"date":"2025-03-14","current":179.829719,"twenty":164.766144,"median":174.911776,"eighty":189.692293,"marketCap":5647282174.13},{"date":"2025-03-21","current":184.714961,"twenty":166.589772,"median":175.670662,"eighty":188.147066,"marketCap":5803981960.09},{"date":"2025-03-28","current":187.327482,"twenty":166.94361,"median":178.971501,"eighty":190.960114,"marketCap":5900183330.18},{"date":"2025-04-04","current":159.860903,"twenty":166.94361,"median":178.262158,"eighty":189.692293,"marketCap":5073492527.81},{"date":"2025-04-11","current":177.179731,"twenty":166.589772,"median":177.679515,"eighty":188.147066,"marketCap":5496976372.28},{"date":"2025-04-17","current":173.797147,"twenty":166.916392,"median":177.619467,"eighty":187.883767,"marketCap":5535140863.85},{"date":"2025-04-25","current":193.309359,"twenty":167.052484,"median":178.059203,"eighty":190.062144,"marketCap":6172717887.8},{"date":"2025-05-02","current":198.453445,"twenty":167.392713,"median":178.295984,"eighty":190.062144,"marketCap":6327668326.52},{"date":"2025-05-09","current":181.396737,"twenty":167.481337,"median":179.235568,"eighty":190.062144,"marketCap":5809793224.05},{"date":"2025-05-16","current":176.029393,"twenty":167.481337,"median":178.295984,"eighty":189.78972,"marketCap":5619140101.04},{"date":"2025-05-23","current":172.647682,"twenty":167.528804,"median":178.059203,"eighty":189.451294,"marketCap":5528513460.13},{"date":"2025-05-30","current":176.779306,"twenty":167.780801,"median":177.456621,"eighty":188.460572,"marketCap":5687082652.57},{"date":"2025-06-06","current":173.121803,"twenty":167.88049,"median":177.318176,"eighty":187.949592,"marketCap":5638091901.1},{"date":"2025-06-13","current":167.838743,"twenty":167.88049,"median":176.508379,"eighty":187.45928,"marketCap":5463186103.94},{"date":"2025-06-20","current":168.923551,"twenty":167.889662,"median":176.029393,"eighty":187.353158,"marketCap":5442074695.06},{"date":"2025-06-27","current":165.669807,"twenty":167.592888,"median":175.625224,"eighty":187.337752,"marketCap":5412704421.76},{"date":"2025-07-03","current":162.348276,"twenty":167.428163,"median":175.082406,"eighty":187.024133,"marketCap":5325445922.59},{"date":"2025-07-11","current":163.297285,"twenty":166.671427,"median":174.480785,"eighty":186.439488,"marketCap":5350247552.51},{"date":"2025-07-18","current":171.228286,"twenty":165.90028,"median":173.909122,"eighty":186.045921,"marketCap":5541358073.91},{"date":"2025-07-25","current":144.045965,"twenty":165.670181,"median":173.731386,"eighty":185.637634,"marketCap":4750367012.62},{"date":"2025-08-01","current":136.589468,"twenty":164.955304,"median":173.25664,"eighty":185.381192,"marketCap":4384547406.6},{"date":"2025-08-08","current":119.575098,"twenty":163.364827,"median":173.121803,"eighty":185.031841,"marketCap":3879545892.37},{"date":"2025-08-15","current":118.626089,"twenty":162.985468,"median":172.816584,"eighty":184.520886,"marketCap":3844757658.1},{"date":"2025-08-22","current":367.342977,"twenty":162.565192,"median":172.783145,"eighty":185.031841,"marketCap":3983594342.69},{"date":"2025-08-29","current":297.28853,"twenty":162.917681,"median":173.086118,"eighty":186.439488,"marketCap":3223899680.91},{"date":"2025-09-05","current":280.194275,"twenty":162.97191,"median":173.155042,"eighty":187.353158,"marketCap":3038523660.62},{"date":"2025-09-12","current":284.24913,"twenty":163.053254,"median":173.392729,"eighty":189.722035,"marketCap":3082495919.22},{"date":"2025-09-19","current":299.993591,"twenty":163.181765,"median":173.840405,"eighty":192.411646,"marketCap":3253234303.96},{"date":"2025-09-26","current":303.368871,"twenty":163.269039,"median":174.34097,"eighty":195.332201,"marketCap":3289837005.56},{"date":"2025-10-03","current":316.222238,"twenty":163.331056,"median":174.844246,"eighty":197.182743,"marketCap":3429223360.77},{"date":"2025-10-10","current":308.943311,"twenty":163.584606,"median":175.579785,"eighty":198.432664,"marketCap":3350288154.24},{"date":"2025-10-17","current":337.724829,"twenty":164.112905,"median":175.99796,"eighty":200.117317,"marketCap":3662404902.51},{"date":"2025-10-24","current":335.676999,"twenty":164.422238,"median":176.508379,"eighty":204.373856,"marketCap":3640197520.67},{"date":"2025-10-31","current":328.898919,"twenty":164.871944,"median":177.318176,"eighty":280.077091,"marketCap":3566693671.28},{"date":"2025-11-07","current":302.845362,"twenty":165.230483,"median":178.059203,"eighty":285.744085,"marketCap":3284159889.46},{"date":"2025-11-14","current":289.051675,"twenty":165.371547,"median":178.295984,"eighty":290.299055,"marketCap":3134576370.19},{"date":"2025-11-21","current":278.19044,"twenty":165.561349,"median":179.014446,"eighty":289.541689,"marketCap":3016793389.39},{"date":"2025-11-28","current":310.533522,"twenty":165.669807,"median":179.412236,"eighty":291.060611,"marketCap":3367532955.32},{"date":"2025-12-05","current":306.208941,"twenty":165.670741,"median":180.00406,"eighty":294.691227,"marketCap":3320635708.33},{"date":"2025-12-12","current":286.055209,"twenty":165.873166,"median":180.584513,"eighty":295.905706,"marketCap":3102081667.78},{"date":"2025-12-19","current":244.707348,"twenty":165.940952,"median":181.091444,"eighty":294.691227,"marketCap":2653691145.03},{"date":"2025-12-26","current":248.848958,"twenty":166.394684,"median":181.60348,"eighty":294.390689,"marketCap":2698604201.29},{"date":"2026-01-02","current":236.757004,"twenty":166.574536,"median":182.507221,"eighty":293.840477,"marketCap":2567474872.89},{"date":"2026-01-09","current":234.880062,"twenty":166.797362,"median":182.734458,"eighty":292.111558,"marketCap":2547120662.92},{"date":"2026-01-16","current":240.619616,"twenty":166.998047,"median":183.212494,"eighty":291.104403,"marketCap":2609362374.53},{"date":"2026-01-23","current":233.793317,"twenty":167.188576,"median":183.578507,"eighty":290.823686,"marketCap":2535335622.99},{"date":"2026-01-30","current":230.611959,"twenty":167.428163,"median":183.988776,"eighty":290.419247,"marketCap":2500835870.83},{"date":"2026-02-06","current":214.320895,"twenty":167.500324,"median":184.979028,"eighty":290.056234,"marketCap":2324169939.4},{"date":"2026-02-13","current":194.105832,"twenty":167.571527,"median":185.74722,"eighty":289.461299,"marketCap":2104950801.53},{"date":"2026-02-20","current":-349.931165,"twenty":167.550165,"median":186.245055,"eighty":289.186438,"marketCap":2493259551.93},{"date":"2026-02-27","current":-337.576812,"twenty":166.94361,"median":185.358176,"eighty":288.884688,"marketCap":2405234781.68},{"date":"2026-03-06","current":-357.014534,"twenty":165.886723,"median":184.229774,"eighty":287.796958,"marketCap":2543728559.75},{"date":"2026-03-13","current":-380.87359,"twenty":165.371547,"median":183.661424,"eighty":286.105301,"marketCap":2713724328.68},{"date":"2026-03-20","current":-427.441295,"twenty":164.112905,"median":183.427298,"eighty":285.888656,"marketCap":3045519229.47},{"date":"2026-03-27","current":-448.04178,"twenty":163.181765,"median":182.800475,"eighty":285.212188,"marketCap":3192297684.03},{"date":"2026-04-02","current":-425.435204,"twenty":162.890567,"median":182.629922,"eighty":285.17117,"marketCap":3031225831.43},{"date":"2026-04-10","current":-492.382264,"twenty":161.467054,"median":181.810223,"eighty":284.24913,"marketCap":3508223631.57},{"date":"2026-04-17","current":-499.465833,"twenty":158.955031,"median":181.091444,"eighty":284.07528,"marketCap":3558694058.36},{"date":"2026-04-24","current":-507.89561,"twenty":156.233199,"median":180.584513,"eighty":282.031139,"marketCap":3618756217.23},{"date":"2026-05-01","current":-532.518745,"twenty":154.872282,"median":180.00406,"eighty":281.147736,"marketCap":3794196059.21},{"date":"2026-05-08","current":-508.824558,"twenty":144.045965,"median":179.412236,"eighty":280.966174,"marketCap":3625374971.37},{"date":"2026-05-15","current":-506.065728,"twenty":140.182144,"median":178.86094,"eighty":280.209239,"marketCap":3605718311.9},{"date":"2026-05-22","current":-452.537308,"twenty":125.947014,"median":178.262158,"eighty":280.194275,"marketCap":3224328322.29},{"date":"2026-05-29","current":-444.681415,"twenty":120.122064,"median":178.059203,"eighty":279.725537,"marketCap":3168355079.47},{"date":"2026-06-05","current":-452.683664,"twenty":115.968865,"median":177.318176,"eighty":279.589795,"marketCap":3225371110.32},{"date":"2026-06-12","current":-453.131496,"twenty":29.784924,"median":176.508379,"eighty":278.469383,"marketCap":3228561906.13},{"date":"2026-06-18","current":-479.232706,"twenty":-319.885885,"median":176.029393,"eighty":275.361846,"marketCap":3414533028.17},{"date":"2026-06-26","current":-505.22407,"twenty":-336.088027,"median":175.625224,"eighty":265.637187,"marketCap":3599721496.58},{"date":"2026-07-02","current":-567.292731,"twenty":-347.690038,"median":175.082406,"eighty":259.576863,"marketCap":4041960704.33},{"date":"2026-07-10","current":-538.02731,"twenty":-371.335373,"median":174.480785,"eighty":256.751103,"marketCap":3833444584.84},{"date":"2026-07-17","current":-497.824928,"twenty":-406.861587,"median":173.909122,"eighty":252.484997,"marketCap":3547002606.6},{"date":"2026-07-24","current":-487.362208,"twenty":-419.925535,"median":173.731386,"eighty":249.449835,"marketCap":3472455733.71},{"date":"2026-07-31","current":-475.018244,"twenty":-425.317007,"median":173.324997,"eighty":249.116107,"marketCap":3384504988.78},{"date":"2026-08-07","current":-543.110083,"twenty":-431.380818,"median":173.121803,"eighty":248.587668,"marketCap":3869659340.88},{"date":"2026-08-14","current":-563.285348,"twenty":-444.416873,"median":172.850024,"eighty":247.242146,"marketCap":4013408103.64},{"date":"2026-08-21","current":112.812357,"twenty":-445.662886,"median":172.57995,"eighty":245.774025,"marketCap":3778875522.96},{"date":"2026-08-28","current":114.191675,"twenty":-444.681415,"median":171.69944,"eighty":244.665977,"marketCap":3825078550.57},{"date":"2026-09-04","current":120.218119,"twenty":-444.416873,"median":171.125205,"eighty":244.246526,"marketCap":4026946335.18},{"date":"2026-09-11","current":113.993217,"twenty":-443.358706,"median":170.839525,"eighty":243.230652,"marketCap":3818430784.57},{"date":"2026-09-18","current":128.771395,"twenty":-438.399131,"median":170.279278,"eighty":242.301839,"marketCap":4313455406.44},{"date":"2026-09-25","current":113.11909,"twenty":-435.525335,"median":170.22876,"eighty":242.197204,"marketCap":3789150143.08},{"date":"2026-10-02","current":106.450812,"twenty":-432.365699,"median":169.774316,"eighty":242.047247,"marketCap":3565782844.39},{"date":"2026-10-07","current":112.049061,"twenty":-429.411057,"median":169.604202,"eighty":241.190668,"marketCap":3753307402.38}],"updateTime":1791473054940},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664364819","title":"Telix Pharmaceuticals Price Target Maintained with a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664364819","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664364819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:44","pubTimestamp":1788349440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664867645","title":"Telix Pharmaceuticals Completes Patient Enrollment in Phase Three Study of PSMA-PET Imaging Agents for Prostate Cancer Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2664867645","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664867645?lang=en_us&edition=fundamental","pubTime":"2026-09-02 08:50","pubTimestamp":1788310213,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) completed patient enrollment in the phase three BiPASS study of its prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging agents Gozellix a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","TLX","TLX.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664649208","title":"Telix Wraps Phase 3 BiPASS Enrollment, Secures FDA NDA Pathway for Expanded PSMA-PET Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2664649208","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664649208?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:40","pubTimestamp":1788302458,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an announcement. Telix Pharmaceuticals has completed enrollment of 350 patients in its Phase 3 Bi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wraps-phase-3-bipass-enrollment-secures-fda-nda-pathway-for-expanded-psma-pet-use?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wraps-phase-3-bipass-enrollment-secures-fda-nda-pathway-for-expanded-psma-pet-use?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4139","LABU","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664320861","title":"ASX Growth Companies With High Insider Ownership You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2664320861","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664320861?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:08","pubTimestamp":1788289704,"startTime":"0","endTime":"0","summary":"Amidst a backdrop of geopolitical tensions in the Middle East and fluctuating oil prices, the Australian market is experiencing volatility, with the S&P/ASX 200 expected to open lower following Wall Street's decline. In such uncertain times, identifying growth companies with high insider ownership can offer insights into potential resilience and confidence within those businesses.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","IOZ.AU","XKO.AU","EIQ.AU","IIGF.AU","LTR.AU","XAO.AU","BK4139","E200.AU","IMLC.AU","SPL.AU","BK7096","TLX.AU","TTT.AU","ZYAU.AU","BBOZ.AU","FRS.AU","GIVE.AU","XJO.AU","DACE.AU","BK7110","BK7501","BK7504","WZR.AU","VAS.AU","BEAR.AU","GYG.AU","STW.AU","VAP.AU","QRE.AU","BK7137","SKS.AU","BK7093","PDI.AU","QFN.AU","AV1.AU","EIGA.AU","BK7067","TLX","SLF.AU","BK7016","GEAR.AU","BK7036","BK7508","OZF.AU","AWJ.AU","OZR.AU","IISV.AU","BK7023","AR1.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664688572","title":"Press Release: Telix Appoints David Gill as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2664688572","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664688572?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:21","pubTimestamp":1788214860,"startTime":"0","endTime":"0","summary":"-- David Gill appointed Chair of the Telix Board, effective immediately.-- Mr. Gill joined Telix as a Non-Executive Director in May 2026, with the. -- Dr. Mark Nelson will continue to serve on the Board as a Non-Executive","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","EOLS","BK4604","BK4022","BK4555","BK4141","BK4007","TLX.AU","BK4139","BK4588","BK4526","ASX","03160","TLX","BK7067","BK4232","BK4585","TM","BK4543","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663833045","title":"Cochlear Stock And Two ASX Cash Flow Picks Trading Below Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2663833045","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663833045?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:29","pubTimestamp":1788046160,"startTime":"0","endTime":"0","summary":"With central banks focused on inflation that has not meaningfully slowed, investors are paying closer attention to cash flows and valuation discipline. When policy makers keep rates in focus, solid cash generation can matter more than short term sentiment swings. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that combine discounted SWS DCF valuations with attractive cash flow potential for patient, value-oriented investors.\nThe three stocks in...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-stock-and-two-asx-cash-flow-picks-trading-below-fai","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-stock-and-two-asx-cash-flow-picks-trading-below-fai","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7507","COH.AU","SPHQ","BK4588","BK4139","BK7095","CDIG","TLX","LYC.AU","BK7007","TLX.AU","TACU","BK7067","TSPA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603266","title":"3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603266","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662603266?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:27","pubTimestamp":1787862425,"startTime":"0","endTime":"0","summary":"Global consumer confidence is starting to improve in places like Germany, Finland and Taiwan. That matters for growth focused companies that rely on people and businesses feeling comfortable enough to spend. When demand holds up, management teams often feel more confident about backing their own plans with personal capital. This article looks at three fast growing stocks with high insider ownership that fit that story today.\nThe three stocks below are just a starting sample, and the full...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","BEAR.AU","DACE.AU","STW.AU","BBOZ.AU","VAS.AU","IISV.AU","XKO.AU","QFN.AU","SLF.AU","OZF.AU","TLX","BK7067","IMLC.AU","TLX.AU","IOZ.AU","E200.AU","GIVE.AU","VAP.AU","BK7095","BK7104","QRE.AU","XAO.AU","LIN.AU","XJO.AU","IIGF.AU","OZR.AU","BK4139","EIGA.AU","PDI.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771276","title":"Cash Flow Stocks Retail Investors May Be Missing In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771276","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771276?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:25","pubTimestamp":1787808304,"startTime":"0","endTime":"0","summary":"Central banks in Europe are still signalling possible rate hikes to contain inflation. That keeps pressure on broad equity valuations and makes reliable cash generation more valuable. When investors worry about the path of rates, stocks with strong cash flow support and discounts to estimated fair value can look appealing. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that fit that profile.\nThe stocks covered below are just a small sample, and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/cash-flow-stocks-retail-investors-may-be-missing-in-australi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/cash-flow-stocks-retail-investors-may-be-missing-in-australi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","WTC.AU","BK7016","BK4585","VAS.AU","BBOZ.AU","QFN.AU","STW.AU","XJO.AU","BK7508","BK7501","ISBC","VAP.AU","XAO.AU","XKO.AU","GIVE.AU","BEAR.AU","EIGA.AU","IMLC.AU","TLX","SLF.AU","BK4588","TLX.AU","E200.AU","OZR.AU","BK4139","IIGF.AU","BK7067","SPHQ","IOZ.AU","OZF.AU","BK4211","QRE.AU","ZYAU.AU","IISV.AU","MSB.AU","DACE.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662861786","title":"Telix Pharmaceuticals Stock Leads 3 ASX Picks Trading Below Cash Flow Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662861786","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662861786?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:41","pubTimestamp":1787632877,"startTime":"0","endTime":"0","summary":"With Germany’s 10 year Bund yields sitting near multi year highs as investors focus on inflation and tighter policy risk, a lot of attention has shifted back to dependable cash flows and what investors are paying for them. That sets the stage for mispriced opportunities where discounted cash flow values and market prices do not line up. This article highlights three undervalued cash flow stocks from the SWS DCF screener that may warrant a closer look.\nThe three stocks highlighted below are...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-leads-3-asx-picks-trading-below","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-leads-3-asx-picks-trading-below","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK7095","LYC.AU","SPHQ","BK7067","BK7507","TLX","BK4139","WTC.AU","TLX.AU","BK7016","BK4585","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662720056","title":"3 Fast Growing Australian Stocks With High Insider Ownership Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2662720056","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662720056?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:24","pubTimestamp":1787610259,"startTime":"0","endTime":"0","summary":"Euro Area consumer confidence just reached its strongest reading since February, even as investors watch energy and policy risks. When households feel more secure, companies with fast growth and high insider ownership can be well placed to turn that optimism into revenues and reinvestment. This article highlights 3 stocks from the Fast Growing Stocks With High Insider Ownership screener that align with this backdrop.\nThe three stocks covered below are just a sample, and the full screen...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/3-fast-growing-australian-stocks-with-high-insider-ownership-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/3-fast-growing-australian-stocks-with-high-insider-ownership-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IIGF.AU","ZYAU.AU","GIVE.AU","BK7508","MSB.AU","BK7501","TLX.AU","E200.AU","BK4139","OZF.AU","EIGA.AU","BK7095","VAS.AU","GEAR.AU","SLF.AU","IMLC.AU","QRE.AU","DACE.AU","XKO.AU","IISV.AU","BBOZ.AU","VAP.AU","IOZ.AU","BEAR.AU","XJO.AU","TLX","BK7067","STW.AU","XAO.AU","LIN.AU","OZR.AU","QFN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820966","title":"ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820966","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820966?lang=en_us&edition=fundamental","pubTime":"2026-08-25 03:04","pubTimestamp":1787598287,"startTime":"0","endTime":"0","summary":"As the Australian market looks to start the week on a positive note, buoyed by encouraging movements on Wall Street and a resilient commodities sector, investors are keenly observing opportunities for growth amidst fluctuating economic indicators like unemployment rates. In this environment, identifying stocks trading below their intrinsic value can offer potential advantages, as these investments may provide room for appreciation when market confidence is bolstered by favorable global and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/telecom/asx-slc/superloop-shares/news/asx-august-2026-stocks-estimated-to-be-trading-below-intrins","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/telecom/asx-slc/superloop-shares/news/asx-august-2026-stocks-estimated-to-be-trading-below-intrins","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARX.AU","BK7016","BGL.AU","BK7084","SLC.AU","BK7505","BK7055","BK7094","TEA.AU","BK7015","TLX.AU","BK4139","TLX","ELS.AU","RDY.AU","BK7141","BK7501","BK7508","BK7126","BK7104","CGS.AU","MSB.AU","ING.AU","BK4585","SPHQ","BK4588","BK7067","PNV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661422332","title":"Ord Minnett Reaffirms Their Buy Rating on Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661422332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661422332?lang=en_us&edition=fundamental","pubTime":"2026-08-24 10:06","pubTimestamp":1787537166,"startTime":"0","endTime":"0","summary":"In a report released today, from Ord Minnett maintained a Buy rating on Telix Pharmaceuticals, with a price target of A$20.40. In addition to Ord M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ord-minnett-reaffirms-their-buy-rating-on-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ord-minnett-reaffirms-their-buy-rating-on-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLPPF","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661241216","title":"WiseTech Global Stock And 2 Australian Shares Trading Below Cash Flow Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2661241216","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661241216?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:23","pubTimestamp":1787527420,"startTime":"0","endTime":"0","summary":"US services activity is growing at its strongest pace in nearly two years, which keeps cash rich companies in focus as investors watch how inflation and interest rate views evolve. When earnings quality matters more, stocks that generate solid cash flows yet trade below estimated fair value can attract fresh attention. This article looks at three stocks from the Undervalued Stocks Based On Cash Flows screener.\nThe stocks highlighted below are just a sample from this idea, with the full screen...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/wisetech-global-stock-and-2-australian-shares-trading-below-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/wisetech-global-stock-and-2-australian-shares-trading-below-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QRE.AU","TLX.AU","BBOZ.AU","BK4588","BK7016","EIGA.AU","IIGF.AU","IOZ.AU","BEAR.AU","WTC.AU","ZYAU.AU","IMLC.AU","LYC.AU","BK4139","BK7067","OZR.AU","SLF.AU","XJO.AU","BK7095","XKO.AU","DACE.AU","IISV.AU","GEAR.AU","SPHQ","E200.AU","OZF.AU","XAO.AU","GIVE.AU","BK7507","BK7503","QFN.AU","BK4585","VAS.AU","VAP.AU","TLX","STW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661624340","title":"Mesoblast Stock Leads 3 Fast Growing ASX Picks With Strong Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2661624340","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661624340?lang=en_us&edition=fundamental","pubTime":"2026-08-23 22:22","pubTimestamp":1787494952,"startTime":"0","endTime":"0","summary":"Global purchasing manager surveys point to resilient services activity even as some manufacturing data stays mixed. That kind of steady demand can be helpful for fast growing companies where insiders already hold a meaningful stake. When managers and founders keep skin in the game, their interests are closely tied to yours. This article highlights three stocks from the Fast Growing Stocks With High Insider Ownership screener that fit that profile.\nThe three stocks below are only a starting...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-stock-leads-3-fast-growing-asx-picks-with-strong-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-stock-leads-3-fast-growing-asx-picks-with-strong-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","LIN.AU","TLX.AU","BK7067","BK7095","MSB.AU","TLX","MESO","BK4139","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661749248","title":"Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Takeda Pharmaceutical Co (OtherTKPHF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661749248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661749248?lang=en_us&edition=fundamental","pubTime":"2026-08-23 20:20","pubTimestamp":1787487616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Telix Pharmaceuticals (TLPPF) and Takeda Pharmaceuti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-telix-pharmaceuticals-othertlppf-and-takeda-pharmaceutical-co-othertkphf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-telix-pharmaceuticals-othertlppf-and-takeda-pharmaceutical-co-othertkphf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","LU0029874061.USD","XLV","BK4585","BK4139","TLX","BK4581","XBI","TLPPF","BK4588","HCSG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661122682","title":"Cash Flow Stocks Worth A Closer Look As Bond Yields Stay High","url":"https://stock-news.laohu8.com/highlight/detail?id=2661122682","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661122682?lang=en_us&edition=fundamental","pubTime":"2026-08-23 05:26","pubTimestamp":1787434011,"startTime":"0","endTime":"0","summary":"Global bond market volatility has pushed government yields in the US, Canada and Euro Area to elevated levels, which makes dependable cash generation even more valuable to investors seeking stability. When markets focus on income and resilience, stocks that produce strong cash flows yet trade below fair value can attract renewed attention. This article highlights 3 stocks from the Undervalued Stocks Based On Cash Flows screener that fit that theme.\nThe 3 stocks below are a sample of what this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/cash-flow-stocks-worth-a-closer-look-as-bond-yields-stay-hig","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/cash-flow-stocks-worth-a-closer-look-as-bond-yields-stay-hig","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["US5Y.BOND","MVPS","TMF","BK7503","BK7067","US30Y.BOND","WTC.AU","US3Y.BOND","BK4585","BK4588","LYC.AU","US10Y.BOND","BK7016","BK7095","SPHQ","TLX.AU","US12M.BOND","US6M.BOND","US7Y.BOND","BK7507","TLT","US2Y.BOND","BK4139","TLX","TLTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661215007","title":"Jarden Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661215007","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661215007?lang=en_us&edition=fundamental","pubTime":"2026-08-22 13:36","pubTimestamp":1787376980,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Steven Wheen from Jarden maintained a Buy rating on Telix Pharmaceuticals, with a price target of A$20.70. The comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jarden-keeps-their-buy-rating-on-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jarden-keeps-their-buy-rating-on-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","TLPPF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661257927","title":"Mesoblast Stock Leads 3 High Growth Insider Owned ASX Shares To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2661257927","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661257927?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:27","pubTimestamp":1787279279,"startTime":"0","endTime":"0","summary":"Central banks are openly debating future rate moves as inflation data sends mixed signals. That kind of uncertainty keeps many investors on the sidelines. It also creates room for fast growing stocks with high insider ownership, where managers and shareholders are clearly aligned. This article looks at three stocks from the Fast Growing Stocks With High Insider Ownership screener that fit that profile right now.\nThe stocks covered below are only a starting sample from this theme, and the full...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/mesoblast-stock-leads-3-high-growth-insider-owned-asx-shares","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/mesoblast-stock-leads-3-high-growth-insider-owned-asx-shares","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MESO","MSB.AU","BK7508","BK7067","BK7104","BK4139","TLX","PDI.AU","BK7501","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661236101","title":"Telix Pharmaceuticals Price Target Maintained with a $22.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2661236101","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661236101?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:57","pubTimestamp":1787245020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728389","title":"Telix Pharmaceuticals: Buy Rating Reiterated with Unchanged $31 Target Ahead of Key Pixclara Regulatory Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728389","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728389?lang=en_us&edition=fundamental","pubTime":"2026-08-20 17:55","pubTimestamp":1787219720,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Laura Sutcliffe from Citi maintained a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/telix-pharmaceuticals-buy-rating-reiterated-with-unchanged-31-target-ahead-of-key-pixclara-regulatory-catalyst-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/telix-pharmaceuticals-buy-rating-reiterated-with-unchanged-31-target-ahead-of-key-pixclara-regulatory-catalyst-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":199,"code":"91000000","status":"200"}]}}